Clinical Trial Update: Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether adding human placental membrane products to standard of care improves outcomes for nonhealing diabetic foot ulcers and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Venous Leg Ulcer

Drugs mentioned

• Human placental membrane products

Snippet

Sponsor: BioLab Holdings | Conditions: Diabetic Foot, DFU | Phase 4 | Status: RECRUITING